Aller au contenu
MediHelp
MediHelp Référence médicamenteuse

Interactions médicamenteuses

Anagrelide + Ponesimod

Gravité: Majeure

Anagrelide and Ponesimod: major interaction.

Dernière mise à jour

Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.

Le contenu clinique de cette page n'est disponible qu'en anglais.

Résumé

Ponesimod slows heart rate and can affect conduction, and anagrelide can prolong QT, so the combination may raise arrhythmia risk, particularly with bradycardia. The concern is greatest in patients with existing heart disease.

Ce que signifie cette interaction, en termes simples

Anagrelide and Ponesimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Anagrelide belongs to Cardiovascular; Ponesimod belongs to Central Nervous System.

Niveau de preuve: Low

Pourquoi elle survient

Additive effects: ponesimod-induced bradycardia increases vulnerability to anagrelide-related QT prolongation.

Conduite à tenir

Obtain an ECG before starting ponesimod and seek cardiology advice if QT-prolonging drugs are required. Monitor heart rate and QTc after initiation.

Questions à poser à votre pharmacien

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Réservé aux membres Pro+

Débloquer la page complète

Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Anagrelide et Ponesimod, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription
Créer un compte gratuit Se connecter

Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.

Questions fréquentes

Can I take Anagrelide with Ponesimod?

MediHelp rates the interaction as major. Anagrelide and Ponesimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ponesimod slows heart rate and can affect conduction, and anagrelide can prolong QT, so the combination may raise arrhythmia risk, particularly with bradycardia. The concern is greatest in patients with existing heart disease.

How serious is the interaction between Anagrelide and Ponesimod?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain an ECG before starting ponesimod and seek cardiology advice if QT-prolonging drugs are required. Monitor heart rate and QTc after initiation.

What other medicines interact with Anagrelide?

MediHelp also lists interactions of Anagrelide with, for example, Panobinostat, Pimozide, Thioridazine. The full list is on the Anagrelide page.

Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp

Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.

Télécharger surApp Store Disponible surGoogle Play

Parcourir de A à Z · Interactions médicamenteuses

Télécharger l'app Se connecter